Nebenwirkungen · Plenadren
Plenadren 5 mg modified-release tablets Plenadren 20 mg modified-release tablets · Abschnitt 4.8 · PDF-Seite 6
HOS-213709 · Präparat HOS-155174
Overall, the frequency and type of adverse reactions were similar for Plenadren once daily modified- release tablets and hydrocortisone tablets given three times daily in a 12-week study. There was an initial increase in the frequency of adverse reactions in about one in five patients, observed up to eight weeks after first changing from conventional hydrocortisone tablets given three times daily to once daily modified-release tablets. However, these adverse reactions (abdominal pain, diarrhoea, nausea and fatigue) are mild or moderate, transient, of short duration but may require dose adjustment or additional concomitant medicinal products, see section 4.2. Fatigue has been reported as very common.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2022-12-06T10:00:00Z · SHA-256 53473ee0edc582bcd44e3accf6dc87633e3875e631a072bc9c72cbe175c453a7 · Passage 31c3c0cd27458ad8c05d136177ae1b2d0678bc31d6c49287b7d86d840cbd0e41 · Zeichen 315–1023 im Abschnitt